Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07043829Not ApplicableCompleted

Cimarrón Bean Extrudate Solution on Platelet Function and Biochemical Parameters

Role: collaborator

NCT07076563Not ApplicableActive Not Recruiting

Ice Cream Enriched With Cimarrón Bean Extrudate and Cardiovascular Risk in Adults

Role: collaborator

NCT07053267Not ApplicableCompleted

Acute Postprandial Effects of Functional Ice Cream With Cimarrón Bean Extrudate in Adults

Role: collaborator

NCT05955131Not ApplicableUnknown

Bread Supplemented With Chilean Beans to Decrease Postprandial Glycoxidative Responses: A Pilot Intervention

Role: collaborator

NCT02986165Not ApplicableCompleted

Effect of Ingesting a Tomato Pomace Extract on Platelet Aggregation

Role: lead

All 5 trials loaded